Seongnam, South Korea

Ji Ye Ahn

This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Qurient Co., Ltd.. Active years: 2017-2018.

USPTO Granted Patents = 2 

% Patents Active = 100.0


 

Average Co-Inventor Count = 6.2

ph-index = 1


Company Filing History:


Years Active: 2017-2018

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ji Ye Ahn: Innovator in Topical Anti-Inflammatory Treatments

Introduction

Ji Ye Ahn is a notable inventor based in Seongnam, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of topical anti-inflammatory treatments. With a total of 2 patents to his name, Ahn is recognized for his innovative approaches to medical formulations.

Latest Patents

Ahn's latest patents include a topical anti-inflammatory pharmaceutical composition featuring a zileuton cream formulation. This formulation is designed to retain stability at room temperature while maximizing medical effects. It minimizes absorption throughout the body, thereby reducing potential toxicity associated with the compound. This makes it particularly suitable for the topical treatment of skin diseases caused by leukotriene.

Career Highlights

Throughout his career, Ji Ye Ahn has focused on creating effective pharmaceutical solutions. His work has been instrumental in advancing treatments that are both safe and effective for patients suffering from inflammatory skin conditions. His dedication to research and development has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Ahn collaborates with talented individuals such as Ki Yean Nam and Jeong Jun Kim. Together, they contribute to the innovative environment at Qurient Co., Ltd., where they work on developing cutting-edge pharmaceutical products.

Conclusion

Ji Ye Ahn's contributions to the field of topical anti-inflammatory treatments highlight his commitment to improving patient care through innovation. His work continues to pave the way for advancements in pharmaceutical formulations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…